In addition, three potential targets of miR-155-5p, interleukin 17 receptor B (IL17RB), interleukin 18 receptor 1 (IL18R1) and interleukin 22 receptor subunit alpha 2 (IL22RA2), have been investigated, indicating it is a modulator of ARDS progression. Here, IL17RB is linked to acute respiratory distress syndrome.